Journal of the American Society of Echocardiography
Volume 23, Issue 8 , Pages 832-839 , August 2010

Prognostic Implications of Stress Echocardiography and Impact on Patient Outcomes: An Effective Gatekeeper for Coronary Angiography and Revascularization

This work was presented in part at the 81st Annual Scientific Sessions of the American Heart Association, New Orleans, LA.

References 

  1. Chaudhry FA. Adenosine stress echocardiography. Am J Cardiol. 1997;79:25–29
  2. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83–90
  3. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97:1474–1480
  4. Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1999;33:708–716
  5. Marwick TH, Case C, Sawada S, Rimmerman C, Brenneman P, Kovacs R, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754–760
  6. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E. Stress echo results predict mortality: A large-scale multicenter prospective international study. J Am Coll Cardiol. 2003;41:589–595
  7. Yao S, Qureshi E, Sherrid MV, Chaudhry FA. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol. 2003;42:1084–1090
  8. Yao S, Qureshi E, Syed A, Chaudhry FA. Novel stress echocardiographic model incorporating the extent and severity of wall motion abnormality for risk stratification and prognosis. Am J Cardiol. 2004;94:715–719
  9. Shiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  10. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1999;34:730–738
  11. Stamm RB, Carabello BA, Mayers DL, Martin RP. Two-dimensional echocardiographic measurement of left ventricular ejection fraction: prospective analysis of what constitutes an adequate determination. Am Heart J. 1982;104:136–144
  12. Bangalore S, Yao S, Puthumana J, Chaudhry FA. Incremental prognostic value of stress echocardiography over clinical and stress electrocardiographic variables in patients with prior myocardial infarction: "warranty time" of a normal stress echocardiogram. Echocardiography. 2006;23:455–464
  13. Bangalore S, Gopinath D, Yao S, Chaudhry FA. Risk stratification using stress echocardiography: incremental prognostic value over historical, clinical and stress electrocardiographic variables across a wide spectrum of Bayesian pretest probability for coronary artery disease. J Am Soc Echocardiogr. 2007;20:244–252
  14. National Center for Health Statistics. Vital statistics of the United States, 1979: vol. II, mortality, part A (DHHS Publication No [PHS] 84-1101). Washington, DC: US Government Printing Office; 1984;
  15. Yao S, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog Cardiov Disease. 2001;43:281–302
  16. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. Economics of Noninvasive Diagnosis (END) Multicenter Study Group The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol. 1999;33:661–669
  17. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–1133
  18. Bateman TM, O'Keefe JH, Dong VM, Barnhart C, Ligon RW. Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy. J Nucl Cardiol. 1995;2:217–223
  19. Nallamothu N, Pancholy SB, Lee KR, Heo J, Iskandrian AS. Impact on exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol. 1995;2:334–338
  20. Miller TD, Hodge DO, Milavetz JJ, Gibbons RJ. A normal stress SPECT scan in an effective gatekeeper for coronary angiography. J Nucl Cardiol. 2007;14:187–193
  21. Yao S, Shah A, Bangalore S, Chaudhry FA. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr. 2007;20:352–358
  22. Fraker TD, Fihn SD, et al. 2002 Chronic Stable Angina Writing Committee; American College of Cardiology; American Heart Association. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina. J Am Coll Cardiol. 2007;50:2264–2274
  23. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516
  24. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–1291
  25. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA. 2008;300:1765–1773
  26. Hendel RC, Budoff MJ, Cardella JF, Chambers CE, Dent JM, Fitzgerald DM, et al. American College of Cardiology; American Heart Association ACC/AHA/ACR/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SIR 2008 key data elements and definitions for cardiac imaging: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). J Am Coll Cardiol. 2009;53:91–124
  27. Hoffmann R, Lethen H, Marwick T, et al. Analysis of inter-institutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 1996;27:330–336
  28. Hoffmann R, Hoffmann R, Lethen H, Marwick T, Rambaldi R, Fioretti P, et al. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol. 1998;82:1520–1524
  29. Chaudhry FA, Tauke JT, Alessandrini RS, Greenfield SA, Tommaso CL, Bonow RO. Enhanced detection of ischemic myocardium by transesophageal dobutamine stress echocardiography: comparison with simultaneous transthoracic echocardiography. Echocardiography. 2000;17:241–253

PII: S0894-7317(10)00366-4

doi: 10.1016/j.echo.2010.05.004

Journal of the American Society of Echocardiography
Volume 23, Issue 8 , Pages 832-839 , August 2010

Article Tools

* Image Usage & Resolution